The patent infringement litigation between Xilinx, Inc. and LSI Corporation and Agere Systems, Inc. was resolved on April 2, 2010.
On November 5, 2009, Agere, a wholly owned subsidiary of LSI,…
Abbott Laboratories’ application to revoke Bayer HealthCare LLC’s Humira(R) patent remains pending.
In its 2009 annual report on Form 10-K, Abbott reported that litigation is pending in the Regional Court in…
Microchip Technology Incorporated entered into a patent portfolio license effective March 31, 2009, with an unrelated third party that covers both issued patents and patent applications and settled alleged infringement…
The trial on Network-1 Security Solution, Inc.’s patent claims against Cisco Systems Inc. is scheduled to begin July 2010.
On February 7, 2008, Network-1 filed patent claims in the Federal District…
Abbott Laboratories’ appeal to the jury’s ruling on New York University and Centocor, Inc.’s patent infringement suit against the company remains pending.
In April 2007, NYU and Centocor filed a lawsuit…
Abbott Laboratories continues to defend Medinol Limited’s patent infringement actions in The Netherlands and Germany.
In its 2009 annual report on Form 10-K filed with the Securities and Exchange Commission, Abbott…
A new trial date has yet to be set for Forest Laboratories Inc.’s patent infringement complaint against Mylan.
In January 2008, Forest Laboratories and Merz, the Company’s licensor for Namenda, commenced…
Forest Laboratories Inc. and other defendants’ motions to dismiss
RxUSA Wholesale, Inc.’s patent infringement suit are pending on
appeal before the United States Court of Appeals for the Second
Circuit.
On July 14, 2006,…
Microchip Technology Incorporated agreed to the terms of a patent license with an unrelated third party during the first quarter of fiscal 2010. The Company signed an agreement on July…
A patent infringement suit filed by PACT XPP Technologies AG against Xilinx Inc. remains pending in the U.S. District Court for the Eastern District of Texas, Marshall Division.
PACT XPP filed…